Jia Fan, Jian Zhou, Xiao-Wu Huang, Qiang Gao, Jieyi Shi, Xiao-bo Cheng, Wenwen Wang, Sidi Wei, Lan Gu, Li Zheng, Shanzhi Gu, Chunyi Hao, Jianhui Wu, Zhongwei Zhao, Rick Xu, Qian Zhang, Bin Li, Yu Tang, Xiaomin Ding, Zongmin Yu. "Objective response rates with Ori-C101, an armored GPC3-directed CAR-T, in heavily pretreated advanced HCC: Updated results from the phase Ib BEACON study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2508